Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Infectious Diseases

• Publication date

  2001-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/322781PMID 11471100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding the timing of HIV transmission from mother to infant.

  2001cited by this paper
• Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

  2001cited by this paper
• Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

  2000cited by this paper
• Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV.

  2000cited by this paper
• Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates ofHIV-1 and HIV-2 in The Gambia

  2000influential reference
• Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera.

  2000cited by this paper
• Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment

  2000influential reference
• Prophylactic and Therapeutic Benefits of Short-Term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine (PMPA) Administration to Newborn Macaques following Oral Inoculation with Simian Immunodeficiency Virus with Reduced Susceptibility to PMPA

  2000cited by this paper
• Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2)

  2000cited by this paper
• Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission

  2000cited by this paper
• Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial.

  1999cited by this paper
• Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects.

  1999cited by this paper
• Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

  1999cited by this paper
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

  1999cited by this paper
• Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus.

  1999cited by this paper
• Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure.

  1999cited by this paper
• HIV-1 drug resistance in newly infected individuals.

  1999cited by this paper
• Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.

  1999cited by this paper
• 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) Therapy Prolongs Survival of Infant Macaques Inoculated with Simian Immunodeficiency Virus with Reduced Susceptibility to PMPA

  1999cited by this paper
• Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group.

  1999cited by this paper
• Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.

  1999cited by this paper
• Early Short-Term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine Treatment Favorably Alters the Subsequent Disease Course in Simian Immunodeficiency Virus-Infected Newborn Rhesus Macaques

  1999cited by this paper
• 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant.

  1999cited by this paper
• Administration of 9-[2-(Phosphonomethoxy)propyl] adenine (PMPA) for Prevention of Perinatal Simian Immunodeficiency Virus Infection in Rhesus Macaques

  1998influential reference
• Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

  1998cited by this paper
• Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis. Vol. 47/No. RR-7.

  1998cited by this paper
• The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.

  1998cited by this paper
• Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV

  1998cited by this paper
• Targeted lymph‐node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251

  1998cited by this paper
• Safety, Pharmacokinetics, and Antiretroviral Activity of Intravenous 9-[2-(R)-(Phosphonomethoxy)propyl]adenine, a Novel Anti-Human Immunodeficiency Virus (HIV) Therapy, in HIV-Infected Adults

  1998cited by this paper
• Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.

  1998cited by this paper
• Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection.

  1998cited by this paper
• Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection

  1998influential reference
• Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9-R-(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

  1998cited by this paper
• Metabolism and Pharmacokinetics of Novel Oral Prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in Dogs

  1997cited by this paper
• Animal studies of prophylaxis.

  1997cited by this paper
• Interaction between timing of perinatal human immunodeficiency virus infection and the design of preventive and therapeutic interventions

  1997cited by this paper
• Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase

  1997cited by this paper
• Human immunodeficiency virus‐indeterminate western blot and abortive infection

  1997cited by this paper
• Reactivation of HIV Type 1 in Chronically Infected Chimpanzees Following Xenostimulation with Human Cells or with Pulses of Corticosteroid

  1997cited by this paper
• Prevention of simian immunodeficiency virus, SIVsm, or HIV‐2 infection in cynomolgus monkeys by pre‐ and postexposure administration of BEA‐005

  1997cited by this paper
• Indeterminate human immunodeficiency virus type 1 western blot may indicate an abortive infection in some low‐risk blood donors

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• 9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaques

  1996cited by this paper
• Persistent Viral Infections

  1996cited by this paper
• Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection.

  1996cited by this paper
• Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

  1996cited by this paper
• Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines.

  1996cited by this paper
• Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine

  1995cited by this paper
• Clearance of HIV infection in a perinatally infected infant

  1995cited by this paper
• Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.

  1995cited by this paper
• Activation of virus replication after vaccination of HIV-1-infected individuals

  1995cited by this paper
• Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques

  1995cited by this paper
• Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS

  1995cited by this paper
• Immune responses in HIV-exposed seronegatives: have they repelled the virus?

  1995cited by this paper
• Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

  1994cited by this paper
• Simian Immunodeficiency Virus

  1994cited by this paper
• Basic and Clinical Biostatistics

  1993cited by this paper
• Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3'-azido-3'-deoxythymidine prevents SIV infection

  1992cited by this paper
• Transient Increases in Numbers of Infectious Cells in an HIV-infected Chimpanzee Following Immune Stimulation

  1992cited by this paper
• Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection.

  1991cited by this paper

• Membrane-permeable tenofovir-di- and monophosphate analogues.

  2023cites this paper
• Pediatric HIV-1 Acquisition and Lifelong Consequences of Infant Infection.

  2019cites this paper
• Population pharmacokinetic and machine learning methods to increase precision of adherence assessments for HIV prevention

  2019cites this paper
• Oral clade C SHIV challenge models to study pediatric HIV-1 infection by breastmilk transmission

  2019cites this paper
• Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria.

  2018cites this paper
• Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens

  2017cites this paper
• Efficacy of HIV Pre Exposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies

  2017cites this paper
• Innate immune potential of primary lymphatic endothelial cells

  2015cites this paper
• Antiretrovirals for Primary HIV Prevention: the Current Status of Pre- and Post-exposure Prophylaxis

  2015cites this paper
• Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies.

  2015cites this paper
• An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.

  2015cites this paper
• Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?

  2015cites this paper
• Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

  2014cites this paper
• Prevention of Sexually Transmitted HIV Infection

  2013cites this paper
• Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial

  2013cites this paper
• Maximizing Effectiveness of HIV Preexposure Prophylaxis Among Men Who Have Sex with Men

  2013cites this paper
• Animal models in virus research: their utility and limitations

  2013cites this paper
• Emtricitabine/Tenofovir Disoproxil Fumarate: A Review of its Use in HIV-1 Pre-Exposure Prophylaxis

  2013cites this paper
• A Vaccine against CCR5 Protects a Subset of Macaques upon Intravaginal Challenge with Simian Immunodeficiency Virus SIVmac251

  2013cites this paper
• From modeling to morals: imagining the future of HIV PREP in Lesotho.

  2013cites this paper
• Antiviral Drugs - Aspects of Clinical Use and Recent Advances

  2012cites this paper
• A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

  2012cites this paper
• Sexual Risk Behaviors and Acceptability of HIV Pre-Exposure Prophylaxis Among HIV-Negative Gay and Bisexual Men in Serodiscordant Relationships: A Mixed Methods Study

  2012cites this paper
• The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies

  2012cites this paper
• Pre-exposure chemoprophylaxis of HIV infection: quo vadis?

  2012cites this paper
• Animal models of HIV transmission through breastfeeding and pediatric HIV infection.

  2012cites this paper
• Use of Animal Models for Anti-HIV Drug Development

  2012influential citation
• Pre-exposure prophylaxis--one more tool for HIV prevention.

  2012cites this paper
• Discovery and Development of Tenofovir Disoproxil Fumarate

  2011cites this paper
• Preexposure Prophylaxis for HIV Prevention

  2011cites this paper
• A 40-year journey in search of selective antiviral chemotherapy.

  2011cites this paper
• AIDS: Drugs that prevent HIV infection

  2011cites this paper
• Acyclic Nucleoside Phosphonates: An Unfinished Story

  2011cites this paper
• Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

  2011cites this paper
• Proof of principle: antiretroviral drugs can prevent sexual transmission of HIV-1

  2011cites this paper
• AIDS Vaccines and Preexposure Prophylaxis: Is Synergy Possible?

  2011cites this paper
• Oral Preexposure Anti-HIV Prophylaxis for High-Risk U.S. Populations: Current Considerations in Light of New Findings

  2011cites this paper
• The clinical potential of the acyclic (and cyclic) nucleoside phosphonates: the magic of the phosphonate bond.

  2011cites this paper
• Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis.

  2010cites this paper
• Recent key advances in human immunodeficiency virus medicine and implications for China

  2010cites this paper
• Oral pre-exposure prophylaxis for HIV prevention.

  2010cites this paper
• Evaluation of antiretrovirals in animal models of HIV infection.

  2010cites this paper
• Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With Men

  2010cites this paper
• Systemic Preexposure Prophylaxis for Human Immunodeficiency Virus Infection

  2010cites this paper
• Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.

  2010cites this paper
• Twenty-six years of anti-HIV drug discovery: where do we stand and where do we go?

  2010cites this paper
• Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice

  2010cites this paper
• Yet another ten stories on antiviral drug discovery (part D): Paradigms, paradoxes, and paraductions

  2010influential citation
• Tolerability of Two Different Combinations of Antiretroviral Drugs Including Tenofovir Used in Occupational and Nonoccupational Postexposure Prophylaxis for HIV

  2010cites this paper
• Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

  2010cites this paper
• Use of Non-Occupational Post-Exposure Prophylaxis does not Lead to an Increase in High Risk Sex Behaviors in Men Who have Sex with Men Participating in the EXPLORE Trial

  2010cites this paper
• Using antiretrovirals to prevent HIV transmission

  2009cites this paper
• Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.

  2009cites this paper
• Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

  2009cites this paper
• The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies.

  2009cites this paper
• Tenofovir disoproxil fumarate in pregnancy and prevention of mother‐to‐child transmission of HIV‐1: is it time to move on from zidovudine?

  2009cites this paper
• Yet another ten stories on antiviral drug discovery (part D): Paradigms, paradoxes, and paraductions

  2009cites this paper
• Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.

  2009cites this paper
• [Pre-exposure prophylaxis in HIV--a vision or soon a reality?].

  2009cites this paper
• Präexpositionsprophylaxe bei HIV – Vision oder bald Realität?

  2009cites this paper
• Drug-Susceptible HIV-1 Infection Despite Intermittent Fixed-Dose Combination Tenofovir/Emtricitabine as Prophylaxis Is Associated With Low-Level Viremia, Delayed Seroconversion, and an Attenuated Clinical Course

  2008cites this paper
• A Therapeutic SIV DNA Vaccine Elicits T-Cell Immune Responses, but No Sustained Control of Viremia in SIVmac239-Infected Rhesus Macaques

  2008cites this paper
• Prevention of the sexual transmission of HIV-1: preparing for success

  2008cites this paper
• Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir

  2008cites this paper
• Chronic Administration of Tenofovir to Rhesus Macaques from Infancy through Adulthood and Pregnancy: Summary of Pharmacokinetics and Biological and Virological Effects

  2008cites this paper
• Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness

  2008cites this paper
• Phospholipase D in the human ocular surface and in pterygium.

  2008cites this paper
• The discovery of antiviral agents: Ten different compounds, ten different stories

  2008cites this paper
• Tenofovir DF Plus Lamivudine or Emtricitabine for Nonoccupational Postexposure Prophylaxis (NPEP) in a Boston Community Health Center

  2008cites this paper
• Limited Knowledge and Use of HIV Post- and Pre-Exposure Prophylaxis Among Gay and Bisexual Men

  2008cites this paper
• BIOPHARMACEUTICAL MICROBICIDES FOR TOPICAL HIV PREVENTION:PRE-CLINICAL EVALUATIONS AND FORMULATION DEVELOPMENT

  2008cites this paper
• Of mice and monkeys: new advances in animal models to study HIV-1 therapy and prophylaxis

  2008cites this paper
• Limited Knowledge and Use of HIV Post- and Pre-Exposure Prophylaxis Among Gay and Bisexual Men

  2008cites this paper
• Postexposure prophylaxis after sexual exposure to HIV

  2007cites this paper
• The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

  2007cites this paper
• Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.

  2007cites this paper
• The acyclic nucleoside phosphonates from inception to clinical use: historical perspective.

  2007cites this paper
• The Microbicide Tenofovir Does Not Inhibit Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples

  2007cites this paper
• Pre-exposure prophylaxis for HIV infection: what if it works?

  2007cites this paper
• Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

  2007cites this paper
• Virology Research

  2007cites this paper
• Post-exposure Prophylaxis and Antiretroviral Pharmacokinetics In the Genital Tract

  2007cites this paper
• Potential Impact of Antiretroviral Chemoprophylaxis on HIV-1 Transmission in Resource-Limited Settings

  2007cites this paper
• Occupational exposure to HIV and the use of post-exposure prophylaxis.

  2007cites this paper
• Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1

  2007cites this paper
• Pre exposure prophylaxis: microbicides and tenofovir based PREP

  2007cites this paper
• SIV Infection of Macaques as a Model for AIDS Drug Studies

  2006cites this paper
• Evaluation of Oral Tenofovir Disoproxil Fumarate and Topical Tenofovir GS-7340 to Protect Infant Macaques Against Repeated Oral Challenges With Virulent Simian Immunodeficiency Virus

  2006cites this paper
• Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women

  2006cites this paper
• From adefovir to Atripla™ via tenofovir, Viread™ and Truvada™

  2006cites this paper
• HIV postexposure prophylaxis for pediatric patients.

  2006cites this paper
• Evidence for Persistent, Occult Infection in Neonatal Macaques following Perinatal Transmission of Simian-Human Immunodeficiency Virus SF162P3

  2006cites this paper
• Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.

  2006cites this paper
• Structured Treatment Interruptions with Tenofovir Monotherapy for Simian Immunodeficiency Virus-Infected Newborn Macaques

  2006cites this paper
• Criteria for Drugs Used in Pre-Exposure Prophylaxis Trials against HIV Infection

  2006cites this paper
• Knowledge and use of HIV pre-exposure prophylaxis among attendees of minority gay pride events, 2004.

  2006cites this paper
• Nucleotide HIV reverse transcriptase inhibitors: tenofovir and beyond

  2006cites this paper
• (C2) Saliva, Breast Milk, and Mucosal Fluids in HIV Transmission

  2006cites this paper
• The global challenge of HIV and AIDS.

  2006cites this paper
• Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

  2006cites this paper